PROFUSA, INC. Proceeds from Convertible Debt
PROFUSA, INC. (PFSA) reported Proceeds from Convertible Debt of $1.45 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2026-08-19
- PROFUSA, INC. proceeds from convertible debt for the quarter ending 2025-06-30 was $700.00K, a 111.61% increase year-over-year.
- PROFUSA, INC. proceeds from convertible debt for the quarter ending 2025-03-31 was $750.00K, a 98.32% increase year-over-year.
- PROFUSA, INC. proceeds from convertible debt for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- PROFUSA, INC. proceeds from convertible debt for the quarter ending 2024-09-30 was -$692.98K, a 301.78% decline year-over-year.
- PROFUSA, INC. proceeds from convertible debt for fiscal 2023 was $1.12M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 9 month as first filed | Proceeds from Convertible Debt 12 month | Proceeds from Convertible Debt 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $1.45M 10-Q · filed 2026-08-19 | $1.45M derived: sum of 3 quarters · filed 2026-08-19 | $757.02K derived: sum of 4 quarters · filed 2026-08-19 | ||
| 2025-03-31 | $750.00K 10-Q · filed 2026-05-15 | $750.00K derived: sum of 2 quarters · filed 2026-05-15 | $57.02K derived: sum of 3 quarters · filed 2026-05-15 | $387.81K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | -$692.98K derived: sum of 2 quarters · filed 2026-05-01 | -$362.19K derived: sum of 3 quarters · filed 2026-05-01 | $16.00K S-1/A · filed 2026-05-01 | $797.98K 10-K · filed 2025-03-31 | |
| 2024-09-30 | -$692.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$362.19K derived: sum of 2 quarters · filed 2025-11-19 | $16.00K 10-Q · filed 2025-11-19 | $787.98K 10-Q · filed 2024-12-17 | $424.80K derived: sum of 4 quarters · filed 2025-11-19 | |
| 2024-06-30 | $330.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $708.98K 10-Q · filed 2025-08-14 | $1.12M derived: sum of 3 quarters · filed 2025-08-14 | $1.46M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $378.19K 10-Q · filed 2025-06-13 | $786.99K derived: sum of 2 quarters · filed 2025-06-13 | $1.13M derived: sum of 3 quarters · filed 2025-06-13 | |||
| 2023-12-31 | $408.80K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $752.23K derived: sum of 2 quarters · filed 2025-03-31 | $1.12M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $343.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | $713.01K 10-Q · filed 2024-12-17 | ||||
| 2023-06-30 | $369.59K 10-Q · filed 2024-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |